ZY Lu
Impact in
- Hematology top 1%
- Multiple Myeloma Research and Treatments
- Hematopoietic Stem Cell Transplantation
- Oncology top 5%
- Cytokine Signaling Pathways and Interactions
- Cancer Immunotherapy and Biomarkers
Papers in
- Hematology 27
- Multiple Myeloma Research and Treatments 20
- Hematopoietic Stem Cell Transplantation 6
- Oncology 15
- Cytokine Signaling Pathways and Interactions 12
- Viral-associated cancers and disorders 2
- Co-authors
- Bernard Klein (39 shared papers)Régis Bataille (16 shared papers)Jean‐François Rossi (27 shared papers)Xueguang Zhang (10 shared papers)Michel Jourdan (8 shared papers)John Wijdenes (11 shared papers)J Brochier (6 shared papers)Zong‐Jiang Gu (7 shared papers)
- Journals
- Blood (12 papers)Bone Marrow Transplantation (3 papers)Frontiers in Immunology (2 papers)The Journal of Immunology (2 papers)Journal of Immunological Methods (2 papers)
- Partner nations
- FranceUnited StatesSpain
In The Last Decade
ZY Lu
45 papers receiving 2.9k citations
Peers
Comparison fields: 5 of 83
- Hematology 1.3k
- Oncology 820
- Immunology 482
- Cancer Research 81
- Radiology, Nuclear Medicine and Imaging 132
Countries citing papers authored by ZY Lu
This map shows the geographic impact of ZY Lu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by ZY Lu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites ZY Lu more than expected).
Fields of papers citing papers by ZY Lu
This network shows the impact of papers produced by ZY Lu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by ZY Lu. The network helps show where ZY Lu may publish in the future.
Co-authors
The 25 scholars most cited alongside ZY Lu, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 45 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 1995 | 456 | |
| 2 | 2015 | 309 | |
| 3 | 1994 | 247 | |
| 4 | 1995 | 226 | |
| 5 | 1994 | 205 | |
| 6 | Interleukin-6 is the central tumor growth factor in vitro and in vivo in multiple myeloma. | 1991 | 111 |
| 7 | 1995 | 107 | |
| 8 | 1992 | 100 | |
| 9 | 1996 | 96 | |
| 10 | 1995 | 81 | |
| 11 | 1998 | 75 | |
| 12 | 2008 | 71 | |
| 13 | 1993 | 69 | |
| 14 | 2007 | 62 | |
| 15 | 2002 | 56 | |
| 16 | 2018 | 53 | |
| 17 | 1998 | 52 | |
| 18 | 2006 | 51 | |
| 19 | 2005 | 47 | |
| 20 | 2016 | 47 |
About ZY Lu
ZY Lu is a scholar working on Hematology, Oncology, Immunology, Pathology and Forensic Medicine and Rheumatology, having authored 45 papers that have together received 3k indexed citations. Recurring topics across this work include Multiple Myeloma Research and Treatments (20 papers), Cytokine Signaling Pathways and Interactions (12 papers), Hematopoietic Stem Cell Transplantation (6 papers), Immunotherapy and Immune Responses (5 papers), T-cell and B-cell Immunology (3 papers), Immune Cell Function and Interaction (3 papers), Lymphoma Diagnosis and Treatment (2 papers) and Viral-associated cancers and disorders (2 papers). The work is most often cited by research in Hematology (1.3k citations), Oncology (820 citations), Immunology (482 citations), Cancer Research (81 citations) and Radiology, Nuclear Medicine and Imaging (132 citations). ZY Lu has collaborated with scholars based in France, United States and Spain. Frequent co-authors include Bernard Klein, Régis Bataille, Jean‐François Rossi, Xueguang Zhang, Michel Jourdan, John Wijdenes, J Brochier, Zong‐Jiang Gu, Jean-Michel Boiron and Hervé Brailly. Their work appears in journals such as Blood, Bone Marrow Transplantation, Frontiers in Immunology, The Journal of Immunology and Journal of Immunological Methods.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.